We are pleased to be attending the upcoming summit in Fremantle this coming Friday and Saturday. Looking forward to discussing GlyTherix Ltd’s targeted radiotherapy program which holds tremendous potential to enhance treatment efficacy while minimizing adverse effects, positioning it as a pivotal advancement in healthcare.
Eager to share more about our technology with those at another great BioShares meeting!